Galectin Therapeutics (GALT) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

GALT Galectin Therapeutics

Watchlist

1.150
+0.280+32.17%

Close Dec 27 16:00 ET

1.120
-0.030-2.61%

Post 19:57 ET

72.18MMarket Cap-1.58P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Galectin Therapeutics Cut to Neutral From Buy by HC Wainwright & Co.
Dow JonesDec 27 11:52 ET · Ratings
Galectin Therapeutics Analyst Ratings
BenzingaDec 27 11:40 ET · Ratings
H.C. Wainwright Downgrades Galectin Therapeutics(GALT.US) to Hold Rating
Moomoo NewsDec 27 11:32 ET · Ratings
H.C. Wainwright Downgrades Galectin Therapeutics After MASH Trial Fails
TipRanksDec 27 11:25 ET
Insider Purchase: Director at $GALT (GALT) Buys 13,469 Shares
Quiver QuantitativeDec 26 08:15 ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
BenzingaDec 20 16:06 ET

Comments

SteadyBoomBipBip

Dec 20 07:09

$Galectin Therapeutics (GALT.US)$ same story with SAVA, 101% the company gone case

Jaguar8

Dec 15 20:58

🔶December 2024 Upcoming Catalysts. Save it. In alphabetical order

$ABVC BioPharma (ABVC.US)$ - Progress continues in our ADHD program with Phase IIb trials at multiple prominent sites. We aim to have an interim report by Q4 2024. ABV-1601 for MDD in cancer patients has completed Phase I study preparation, including the Site Initiation Visit (SIV). The study is set to initiate by the end of 2024.
$Ascent Solar Technologies (ASTI.US)$- Following delivery and the successful completion of the on-orbi...